This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Dermatology
Genetic loci linked to hidradenitis suppurativa identified
Read more
Oral isotretinoin confirmed as most effective treatment for acne in network meta-analysis
Read more
EULAR develops points to consider for psoriasis to psoriatic arthritis transition
Read more
First-in-class oral interleukin-23 inhibitor found to be effective for psoriasis
Read more
Paroxetine found to be effective for refractory erythematous rosacea
Read more
Potential for faecal microbiota transplantation to enhance immunotherapy in advanced melanoma
Read more
Ruxolitinib cream approved by MHRA for non-segmental vitiligo
Read more
Melanoma in situ and mortality: is there cause for concern?
Read more
Amlitelimab found to improve disease severity in moderate to severe atopic dermatitis
Read more
Adalimumab dose increase more effective in obese hidradenitis suppurativa patients
Read more
Ceramide routine significantly reduces local adverse effects from topical acne therapy
Read more
Review suggests biologics safe for pregnant women with psoriasis
Read more
Is topical roflumilast the rising star of dermatological treatments?
Read more
Hope for dystrophic epidermolysis bullosa sufferers after gene therapy approval
Read more
Study finds no increased risk of skin cancer from UVB phototherapy for atopic eczema
Read more
Faster diagnosis and treatment for skin cancer as NHS plans accelerated rollout of teledermatology
Read more
Spironolactone safe and effective for treating acne in women, research confirms
Read more
Page 2 of 7
«
1
2
3
4
5
...
»
Last »
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Ivacaftor use in cystic fibrosis ‘safe and effective’ from one month old, study finds
25 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: